Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ANI Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ANIP
Nasdaq
2834
http://www.anipharmaceuticals.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ANI Pharmaceuticals Inc
ANI Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences
- May 20th, 2022 10:50 am
ANI Pharmaceuticals (ANIP) Reports Q1 Loss, Misses Revenue Estimates
- May 10th, 2022 12:05 pm
ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million
- May 10th, 2022 10:50 am
Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates
- May 9th, 2022 1:15 pm
Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates
- May 5th, 2022 12:55 pm
ANI Pharmaceuticals to Discuss First Quarter 2022 Financial Results on May 10, 2022
- Apr 19th, 2022 10:50 am
ANI Pharmaceuticals Announces the Launch of Misoprostol Tablets
- Apr 11th, 2022 10:50 am
Insider Buying: The ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Chairman Just Bought 10% More Shares
- Mar 24th, 2022 3:46 pm
ANI Pharmaceuticals Appoints Experienced Commercial Leader, Renee P. Tannenbaum, Pharm.D., MBA, to Board of Directors
- Mar 22nd, 2022 8:05 pm
11 Stocks Making Headlines After Earnings Reports
- Mar 17th, 2022 7:00 pm
ANI Pharmaceuticals (ANIP) Lags Q4 Earnings Estimates
- Mar 15th, 2022 1:15 pm
ANI Pharmaceuticals Down 25% After Earnings Miss
- Mar 15th, 2022 12:59 pm
ANI Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Results; Strong Foundation in Place to Drive Sustainable Growth
- Mar 15th, 2022 10:50 am
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
- Mar 7th, 2022 11:50 am
Here's What ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Shareholder Ownership Structure Looks Like
- Mar 2nd, 2022 9:49 am
Cara Therapeutics (CARA) Reports Q4 Loss, Lags Revenue Estimates
- Mar 1st, 2022 10:15 pm
ANI Pharmaceuticals Strengthens Rare Disease Business Unit Leadership Team
- Feb 24th, 2022 11:50 am
BioMarin Pharmaceutical (BMRN) Q4 Earnings and Revenues Top Estimates
- Feb 23rd, 2022 10:25 pm
Oakrum Pharma and ANI Pharmaceuticals Announce the Launch of Betaine Anhydrous Powder, the first Generic Version of Cystadane® (betaine anhydrous for oral solution) Powder, Including 180 Days of Exclusivity
- Feb 14th, 2022 10:00 pm
High Note Wealth, LLC Buys The Walt Disney Co, Uber Technologies Inc, Block Inc, Sells ...
- Feb 1st, 2022 2:38 am
Scroll